VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1037781
Sex: F
Age:
State: MN

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: My lymph node in my neck swelled to the point it stuck out like a robin egg; sores in mouth (roof, gums, and inside lips); sores in nostril; sores on nose and lips; sores on nose and lips; Face swelled significantly on my left side; pink eye; severe headache; sinus pain; jaw main and numbness in my molars; severe shooting nerve pain in my front teeth; This is a spontaneous report from a contactable consumer (patient). A 47-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL9262; expiration date: unknown), via an unspecified route of administration right arm on 23Jan2021 18:45 at a single dose for covid-19 immunization. Medical history included breast cancer survivor as of 11Sep2019. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included venlafaxine hydrochloride (EFFEXOR), clonazepam, anastrozole (ARIMIDEX), vitamin D3, calcium, vitamins NOS (MULTIVITAMIN), "It Works" and "Fat Fighter". The patient previously took fentanyl but had allergies. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that her lymph node in her neck swelled to the point it stuck out like a robin egg. It was mentioned that it was more swelled there as well and super sensitive to touch. These reactions occurred only on left side of her face, sores in mouth (roof, gums, and inside lips) and sores in nostril. She had sores on nose and lips. The patient mentioned that her face swelled significantly on her left side. She had pink eye, severe headache, sinus pain, jaw main and numbness in her molars, severe shooting nerve pain in her front teeth. The events were considered as non-serious and adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since vaccination. The events required treatment for the adverse events that included Keflex, Bactroban, prednisone, Valtrex, and lidocaine viscous-aluminum &magnesium hydrAM. The outcome of the events was recovering.

Other Meds: EFFEXOR; CLONAZEPAM; ARIMIDEX; VITAMIN D3; CALCIUM; MULTIVITAMINS [VITAMINS NOS]

Current Illness:

ID: 1037782
Sex: F
Age:
State: GA

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash; blurred vision; loss of balance; headache; nausea; This is a spontaneous report from a contactable other health care professional (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL3302 and expiration date not provided), via an unspecified route of administration (left arm) first dose on 27Jan2021 08:30 at single dose for Covid-19 immunization. The patient was not pregnant at time of vaccination. The Patient's medical history included Hbp (Blood pressure high). The Patient's concomitant medication included lisinopril, famotidine, and ferrous sulfate. The patient previously took Procardia and Amoxicillin; both experienced allergies. On 28Jan2021, the patient experienced rash, blurred vision, loss of balance, headache, and nausea. The patient did not received treatment for the events. The outcome of the events was recovering. The reporter assesses the events as non-serious. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered in the Hospital. The patient did not tested for covid since vaccination.

Other Meds: LISINOPRIL; FAMOTIDINE; FERROUS SULFATE

Current Illness:

ID: 1037783
Sex: F
Age:
State: OK

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Injection site was moderately sore; I felt extremely tired and fatigued; chilled to the bone alternating with hot spells; This is a spontaneous report from a contactable consumer. A 53-year-old female consumer reported that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL8982), into the left arm on 29Jan2021 at 10:30 at single dose for COVID-19 immunization. Age at vaccination 53 Years. The patient had received first dose of BNT162B2 on 09Jan2021. The patient had no allergies to medications, food, or other products. Medical history was none. Concomitant drugs included Prozac daily and Lyrica one daily. The patient reported that the injection site was moderately sore. The main side effect started 24 hours post shot. She felt extremely tired and fatigued as well as chilled to the bone alternating with hot spells. No body aches. No other effects. No treatment was received. Resolved in 24 hours.

Other Meds: PROZAC; LYRICA

Current Illness:

ID: 1037784
Sex: F
Age:
State: KS

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Moderate to severe muscle aches; joint pain; fatigue; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: EK9231, expiry date: not reported), via an unspecified route of administration on 07Jan2021 05:30 PM at a single dose on the right arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history included arthritis, hypersomnia, depression, anxiety, IBS (irritable bowel syndrome) and allergy to sulfa. Concomitant medications included desvenlafaxine succinate (PRISTIQ), modafinil (MODAFINIL), fluticasone propionate (FLONASE), ibuprofen (IBUPROFEN). The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EK5730) on 16Dec2020 05:30 PM at a single dose on the right arm for COVID-19 immunization (age at vaccination: 37-year-old). On 08Jan2021 07:00 AM, the patient experienced moderate to severe muscle aches, joint pain, and fatigue. No treatment was received for the events. Outcome of the events was recovered/resolved with sequel. The reporter assessed the events as non-serious. Since the vaccination, the patient not been tested for COVID-19.

Other Meds: PRISTIQ; MODAFINIL; FLONASE [FLUTICASONE PROPIONATE]; IBUPROFEN

Current Illness:

ID: 1037785
Sex: F
Age:
State: KY

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: fever; Result Unstructured Data: Test Result:100; Test Date: 20210130; Test Name: fever; Result Unstructured Data: Test Result:103.4; Test Date: 20210124; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: lymph node soreness size of small orange/enlarged lymph node; Fever of 103.4/Day 3 still temp of 100; lymph node soreness size of small orange; This is a spontaneous report from a contactable nurse. A 55-year-old female patient received her second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140) on her left arm, via an unspecified route of administration on 29Jan2021 09:30 at a single dose for covid-19 immunization. Medical history included asthma. Patient previously took codeine and experienced allergies. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 08Jan2021 (first dose). The patient experienced Fever of 103.4 lymph node soreness size of small orange on 30Jan2021 at 01:00AM. Day 3 still temp of 100 and enlarged lymph node. The patient also had a covid test on 24Jan2021 which tested negative.

Other Meds:

Current Illness:

ID: 1037786
Sex: F
Age:
State: FL

Vax Date: 01/22/2021
Onset Date: 01/29/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Hives on breasts, under breasts, chest, lower stomach, on back, under both arms; Hives/ a small one on injection site; This is a spontaneous report from a contactable consumer. A 73-year-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL9262) on her left arm, via an unspecified route of administration on 22Jan2021 14:30 at a single dose for covid-19 immunization. Medical history included arthritis, penicillin allergy, sulphas allergy and Celpholasporins allergy. Concomitant medication included atorvastatin calcium (LIPITOR). The patient previously took sporanox and nitrofurantoin and experienced allergies. It was reported that the patient experienced Hives on breasts, under breasts, chest, lower stomach, on back, under both arms, and a small one on injection site on 29Jan2021 at 10:00PM. The patient received Prednisone twice a day for 5 days as treatment for the events on the emergency room (visit). The outcome of the events was recovering.

Other Meds: LIPITOR [ATORVASTATIN CALCIUM]

Current Illness:

ID: 1037787
Sex: M
Age:
State: AZ

Vax Date: 01/18/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: excruciating pain on the left side my face; rash and swelling on the left side of my face; rash and swelling on the left side of my face; swelling of tongue; tingling in the face and tongue; tingling in the face and tongue; This is a spontaneous report from a contactable consumer (patient). A 39-year-old male patient received the first dose of bnt162b2 (BNT162B2, lot number: el3247, expiry date: not reported), via an unspecified route of administration on 18Jan2021 03:45 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history was none. The patient had no known allergies to medications, food, or other products. The patient had no concomitant medications. On 26Jan2021 06:00 AM, the patient experienced "excruciating pain on the left side my face and then noticed a rash and swelling on the left side of my face and swelling of tongue. Also tingling in the face and tongue." Therapeutic measures received as a result of adverse events included prescribed medication. Adverse events resulted into doctor or other healthcare professional office/clinic visit, emergency room/ department or urgent care. Outcome of the events was not recovered. The reporter assessed the events as non-serious. Since the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1037788
Sex: F
Age:
State: CA

Vax Date: 01/07/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm was killing her for 2 days after the first dose; This is a spontaneous report from a contactable health care professional (patient). A 33-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 07Jan2021 on the arm at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient has not been diagnosed with COVID-19. The patient stated that her arm was killing her for 2 days after the first dose on an unspecified date in Jan2021. The outcome of the event was unknown. The event was reported as non-serious. Since the vaccination, the patient has not been tested for COVID-19. Information on the lot/batch number has been requested

Other Meds:

Current Illness:

ID: 1037789
Sex: F
Age:
State: VA

Vax Date: 12/18/2020
Onset Date: 12/30/2020
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210124; Test Name: PCR; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptoms: severe right extremity pain, radiating down right arm; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; with rt arm weakness, numbness and tingling; brachial plexus neuritis / parsonage turner syndrome; brachial plexus neuritis / parsonage turner syndrome; This is a spontaneous report from a contactable nurse (patient). A 40-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number=EK5730), via an unspecified route of administration on 18Dec2020 09:30 at single dose for COVID-19 immunisation. The patient was vaccinated at hospital. No other vaccine was given within 4 weeks prior to the COVID vaccine. Medical history was none. The patient has no allergies to medications, food, or other products. The patient did not receive concomitant medications. On 30Dec2020 at 03:00 AM the patient experienced onset of severe right extremity pain, radiating down right arm, with rt arm weakness, numbness and tingling, after extensive workup determined to have brachial plexus neuritis / parsonage turner syndrome treated with steroids still recovering would not consider have had total recovery. The events were reported as non serious and resulted in doctor or other healthcare professional office/clinic visit. The patient was treated with steroids. The events were resolving. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, has been tested for COVID-19 (PCR Nasal Swab, negative on 24Jan2021).

Other Meds:

Current Illness:

ID: 1037790
Sex: F
Age:
State: UT

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable conusmer (patient). A 38-year-old female patient received the second dose of bnt162b2 (BNT162B2, lot number: 9L3248, expiry date: not reported), via an unspecified route of administration on 29Jan2021 12:15 PM at a single dose on the left arm for COVID-19 immunization. The most recent COVID-19 vaccine was administered at a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Medical history included migraines, reaction to soy, allergy to penicillin. The patient had no concomitant medications (as reported). Past drug history included estrogen medications which causes migraines and fatigue. The patient previously received the first dose of bnt162b2 (BNT162B2, lot number: EL0140) on 08Jan2021 03:15 PM at a single dose on the left arm for COVID-19 immunization (age at vaccination: 38-year-old). On 30Jan2021 12:45 AM (as reported), the patient experienced soreness in left arm, lasted 72 hrs; woke up after 12 hours with bad headache, muscle aches, chills, fever; headache lasted 36s hours, fever lasted about 36 hours, muscle aches ongoing after 72 hrs, chills still persistent, subside with Tylenol (As reported). After about 60 hours swelling in left arm pit lymph node to about the size of a golf ball, sore all down left flank; after 72 hours swelling in lymph nodes near pubic bone and on neck as well, swelling in arm pit lymph node is decreasing. The patient received Tylenol for chills. She did not receive any treatment for the remaining events. Outcome of the events was recovering. The reporter assessed the events as non-serious. Since the vaccination, the patient not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1037791
Sex: F
Age:
State: TX

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: very bad chills; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on the left arm on 29Jan2021 14:45 at a single dose for COVID-19 immunisation. Medical history included diabetes, cancer and sleep apnea. Concomitant medications were not reported (received within 2 weeks of vaccination). It was reported that 24 hours after getting the shot (30Jan2021 03:00 PM), she had a very bad chills, they lasted at least an hour. 12 hours after that, she got the chills again and 12 hours after that, the same thing. She took acetaminophen (TYLENOL) and that seems to help. Event was reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient was not pregnant. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient had no allergies to medications, food, or other products. Outcome of the event was recovered on an unspecified date. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037792
Sex: F
Age:
State: CA

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210126; Test Name: blood pressure; Result Unstructured Data: Test Result:178/82; Comments: blood pressure went up uncomfortably

Allergies:

Symptoms: my blood pressure went up uncomfortably. 178/82; This is a spontaneous report from a contactable consumer (patient). A 67-year-old non-pregnant female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE; lot number: EL9263; expiration date: unknown), via an unspecified route of administration left arm on 26Jan2021 11:00 at a single dose for covid-19 immunisation. Medical history included hypertension and high cholesterol. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medication included nebivolol hydrochloride (BYSTOLIC), acetylsalicylic acid (BABY ASPIRIN), bumetanide and rosuvastatin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On the day of the vaccination around 5 pm (26Jan2021 05:30 PM), the patient reported that her blood pressure went up uncomfortably to 178/82 [unit unspecified]. The patient did not received treatment for the adverse event. The event was considered as non-serious, but the event resulted in doctor or other healthcare professional office/clinic visit. The patient has not been tested for COVID-19 since the vaccination. The outcome of the event was not recovered.

Other Meds: BYSTOLIC; BABY ASPIRIN; BUMETANIDE; ROSUVASTATIN

Current Illness:

ID: 1037793
Sex: M
Age:
State: IL

Vax Date:
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EN5318, via an unspecified route of administration in the left arm, on an unspecified date at SINGLE DOSE for covid-19 immunization. Medical history included hereditary haemorrhagic telangiectasia. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine (as reported). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medications included benazepril, folic acid, torsemide, tamsulosin and iron. This patient has a history of Hereditary Hemorrhagic Talengiectasia, a bleeding disorder causing very brittle veins in my nose. He gets injections every 6 months to partially control the extreme nosebleeds. Starting the next day after getting the vaccination (30Jan2021, 04:00), there was an increase in the number and intensity of them. It has been the third day and they are getting more frequent. Outcome of events was not recovered. Events are considered non-serious. No follow-up attempts are possible. No further information is expected. Information on the batch/lot number has been obtained.

Other Meds: BENAZEPRIL; FOLIC ACID; TORSEMIDE; TAMSULOSIN; IRON

Current Illness:

ID: 1037794
Sex: M
Age:
State: WA

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore Mouth; This is a spontaneous report from a contactable Nurse. An 86-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on Jan2021 (last week) at SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced sore mouth on Jan2021 (reported as yesterday). The outcome was recovered on Jan2021. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037795
Sex: M
Age:
State: GA

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Flush feeling; tingling in the face, hands and feet; swelling of the tongue and lips; swelling of the tongue and lips; dizziness; This is a spontaneous report from a contactable other healthcare professional (patient). A 65-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EN5318) intramuscular on the left arm on 01Feb2021 10:45 at a single dose for COVID-19 immunization. Medical history included high BP and allergy sulfa drugs. Concomitant medication included losartan, acetylsalicylic acid (BABY ASPIRIN), colecalciferol (D3), zinc and ascorbic acid (VIT C). On 01Feb2021 11:00 AM the patient experienced flush feeling, tingling in the face, hands, and feet, swelling of the tongue and lips and dizziness. Diphenhydramine (BENADRYL) was used to control. Events were reported as non-serious, did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The events resulted to a doctor or other healthcare professional office/clinic visit. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. Outcome of the events was recovered on an unspecified date.

Other Meds: LOSARTAN; BABY ASPIRIN; D3; ZINC; VIT C

Current Illness:

ID: 1037796
Sex: F
Age:
State: VA

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: Covid-19 virus; Test Result: Positive

Allergies:

Symptoms: tested positive for Covid-19 virus; tested positive for Covid-19 virus; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect via a contactable female consumer(patient). A female patient of an unspecified age received first dose BNT162B2, via an unspecified route of administration on 11Jan2021 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient receive 1st dose 11Jan2021, then experienced tested positive for covid-19 virus on Jan2021 with outcome of unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037797
Sex: M
Age:
State: TX

Vax Date: 01/29/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: arm was sore; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a male patient (reporter's husband) of an unspecified age received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date unknown), via an unspecified route of administration on 29Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient's arm was sore on an unspecified date in Jan2021. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037798
Sex: F
Age:
State: CA

Vax Date: 01/15/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable healthcare professional (patient). A 46-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EK9231 and expiry date: 30Apr2021), intramuscular on left arm, on 15Jan2021 13:15 at a single dose for COVID-19 immunization. Medical history included allergic to shampoo products and chemicals and vaccine has Peg). Patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient experienced severe itching and rash in right arm on the 11th day after vaccine administration on 26Jan2021 16:30. It grew from 3.5 inches to as big as 12 inches going around my arm. Patient had to go to emergency room. Adverse event resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Keflex 500mg 4 times a day and bacrim twice a day was given as treatment. Outcome of the events was recovering. Patient was not diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.

Other Meds:

Current Illness:

ID: 1037799
Sex: F
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; chills; feeling generally bad; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date, at single dose, for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that the patient (reporter's wife) experienced headache, chills and was feeling generally bad. The reporter wanted to know if Tylenol can be taken. The outcome of the events was unknown. Information about the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037800
Sex: F
Age:
State: GA

Vax Date: 01/11/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital: Y

Lab Data: Test Date: 202101; Test Name: Covid-19 virus test; Result Unstructured Data: Test Result:positive

Allergies:

Symptoms: Week later she tested positive for Covid virus.; Week later she tested positive for covid virus.; This is a spontaneous report from a Pfizer-sponsored program Pfizer first connect from a contactable consumer. A female patient of an unspecified age received BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration, on 11Jan2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient received COVID vaccine on 11Jan2021. A week later she tested positive for COVID virus. Ended up in hospital. Wanting to know when and if she can get next dose of vaccine. The clinical outcome of the event was not reported. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037801
Sex: F
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: covid; Result Unstructured Data: Test Result:received covid

Allergies:

Symptoms: Inquiring if side effects are from the vaccine. Or if she received covid after the vaccine.; Inquiring if side effects are from the vaccine. Or if she received covid after the vaccine.; This is a spontaneous report from a Pfizer Sponsored program Pfizer First Connect. A contactable registered nurse reported for herself that a female patient of an unspecified age received first and second dose of bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The nurse received both doses of covid vaccine shots. She was inquiring if side effects are from the vaccine or if she received covid after the vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test: received covid. The outcome of the event was unknown. Information on lot/batch number has been requested.; Sender's Comments: Based on the limitedly available information, the lack of efficacy cannot be excluded for vaccine BNT162B2. The case should be reassessed when the administration date of BNT162B2 injection, the test date of SARS-COV-2, medical history and concomitant medication become available.

Other Meds:

Current Illness:

ID: 1037802
Sex: U
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 202101; Test Name: covid test; Test Result: Positive

Allergies:

Symptoms: tested positive for COVID virus; This is a spontaneous report from a Pfizer Sponsored Program. A contactable pharmacist reported for a patient that a patient of unspecified age and gender received first dose of BNT162B2, via an unspecified route of administration in Jan2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The pharmacist reported that last week the patient was given COVID vaccine to Health Care Worker, this week (in Jan2021) the patient had tested positive for COVID virus. Wondering if and when person can get 2nd dose of vaccine. The event outcome was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037803
Sex: F
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital: Y

Lab Data: Test Date: 2012; Test Name: Body temperature; Result Unstructured Data: Test Result:High

Allergies:

Symptoms: The initial case was missing the following minimum criteria: no adverse effect. Upon receipt of follow-up information on 02-Feb-2021 this case now contains all required information to be considered valid. This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A female patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) at single dose, on an unspecified date, in 2012, for immunization. Relevant medical history and concomitant medications were unknown. On an unspecified date, in 2012, the patient was hospitalized with high temperature and swollen arm. She stayed in the hospital for 3 days. Clinical outcome of the events was unknown at time of this report. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037804
Sex: F
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient received 1st dose of Covid vaccine. Right after her husband had tested positive for Covid virus. Patient did not take test. Said had all symptoms. Such as fever, loss of smell, taste, diarrhea and being nauseous on unspecified dates. Was sick for whole month. Patient wondering if she could not get 2nd dose of Covid vaccine or what to do as she wanted to return work. The outcome of the events was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037805
Sex: F
Age:
State: SC

Vax Date: 01/23/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: test; Result Unstructured Data: Test Result:every test has been negative

Allergies:

Symptoms: Very dizzy/ Light headed; I felt very washed out and thought I was tired/ exhausted; Lethargic; She still has a little weakness; Almost like a flare up of Hashimoto; a scalp problem, but nobody knows what it is/ Whatever she has, the vaccine aggravated it 10 times worse; a scalp problem, but nobody knows what it is/ Whatever she has, the vaccine aggravated it 10 times worse; she was feeling bad; The injection site was red, hard, kind of warm; The injection site was red, hard, kind of warm; The injection site was red, hard, kind of warm; joint pain, knees, feet, even my hands; joint pain, knees, feet, even my hands; It felt like some kind of nerve ending issue; She was also very off balance; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient started received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL3249), via an unspecified route of administration at left arm on 23Jan2021at a single dose for COVID-19 immunization. Medical history included ongoing Hashimoto's disease; scalp issue; abrasions on her head like eczema; and weight loss. She was diagnosed a couple of years ago with Hashimoto. A thyroid disorder. She is not on a thyroid medication. They have just been watching it to see. She took the shot. For background, the last couple of months the patient has had abrasions on her head like eczema. She has been going to the Dermatologist for the last year. They have been trying to figure out what is going on. Concomitant medications included Phentermine for weight loss. The patient took the shot on a Saturday 23Jan2021. She did fine Sunday, but by Sunday evening on 24Jan2021, she was feeling bad. On 24Jan2021, the patient experienced injection site really red, hard and warm but didn't hurt; head broken out so bad; and joint pain. On 25Jan2021, the patient felt very dizzy/ light headed, fatigue and lethargic. As the evening went on for two to three days later from the vaccination, she experienced side effects. She got up in the middle of the night that night, and her head was broken out so bad that she couldn't comb her hair. There were least 100-150 small little bumps on her head. They almost feel like they have oil under them. They were sore and very irritated. Her scalp was blood red with inflammation. This has went on the course of 8-9 days. She also had joint pain really bad. Almost like a flare up of Hashimoto. She hasn't been having issues with it. It was like her skin was on fire. Even regular water in the shower feels like it was burning. It felt like some kind of nerve ending issue. She was also very off balance, and light headed. She never ran a fever. She was so exhausted that she couldn't get out of bed for the last 8 days. She is scheduled for the second shot. She is scheduled for the second dose 16Feb2021. Her doctor told her to go ahead and get the other shot, but she would like more information. She did not have a prescribing doctor. She got the vaccine at a a local hospital where she goes for testing. She could never get through to get ahold of the hospital so she tried to go through another facility. She finally got an appointment through the hospital. She was wondering if it is okay to get the second shot. She has had a scalp problem, but nobody knows what it is. They have tried to treat it with a steroid. She has seen several who don't have a clue what is could be. Whatever she has, the vaccine aggravated it 10 times worse. The joint pain was almost 100 % better since yesterday. It was mostly in her feet and knees. She was very dizzy and light headed. She wasn't falling all over the place or anything. That has improved over the last day or two. The first night, she got up to go to the bathroom, and she lost her balance but caught self. she was very careful from then on. She has fatigue as well. She still has a little weakness since the 25Jan2021. She never lost her appetite, but she felt very lethargic since the 25Jan2021. She has recovered from most of these issues, except for her head. She is in very good health except for her thyroid issue. That she has been diagnosed with for a couple of years, and the stuff in her hair. They don't know what has caused that. Every test has been negative. She thought at one point it could be the medication she was on. She was taking Phentermine to lose weight. She was wondering if it would have any recourse, but her doctor said no. She quit taking it the day before the shot just in case. She hadn't taken it again until today. The dose is 37.5mg. The way she felt at first, she felt like she had COVID. The patient stated, "I had some reaction to the (first) Pfizer covid 19 shot I took on 23Jan2021 wanted to ask if I would be able to take the 2nd shot. I took the shot fine, got home. The injection site was red, hard, kind of warm. My arm was never sore but the day after into Sunday I felt very washed out and thought I was tired. I have a thyroid issue, I've been having a scalp problem and this sometimes come with my thyroid issue. Little bumps in my scalp, they were kind of under control because of the Clobetasol propriate foam that I put in my hair and ever since then my skin is on fire. But the main thing I was exhausted, joint pain, knees, feet, even my hands. I laid around and for 5-6 days and today is the first real good day. I still have the bumps but I'm seeing a different dermatologist. I have an over active immune system Hashimoto's disease and something can set up a flare." The outcome of the events almost like a flare up of hashimoto and a scalp problem, but nobody knows what it is/ whatever she has, the vaccine aggravated it 10 times worse was not recovered; events she was feeling bad, joint pain, knees, feet, even my hands, very dizzy/ light headed, i felt very washed out and thought i was tired/ exhausted, lethargic and she still has a little weakness was recovering; events the injection site was red, hard, kind of warm was recovered in Jan2021; and outcome of the other events was unknown.

Other Meds: PHENTERMINE

Current Illness: Hashimoto's disease; Scalp disorder

ID: 1037806
Sex: F
Age:
State: FL

Vax Date:
Onset Date: 01/23/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210123; Test Name: tested; Test Result: Positive

Allergies:

Symptoms: They are supposed to take the 2nd dose of the vaccine tomorrow. However, they tested positive last Saturday; They are supposed to take the 2nd dose of the vaccine tomorrow. However, they tested positive last Saturday; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer (patient) reported similar events for 2 patients. This is the first of two reports. The female patient received first dose of bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported "They are supposed to take the 2nd dose of the vaccine tomorrow. However, they tested positive last Saturday on 23Jan2021. Asking if they should still take the 2nd dose of the vaccine." The patient underwent lab tests and procedures which included test (sars-cov-2 test): positive on 23Jan2021. The outcome of the events was unknown. No follow-up attempts possible. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021106620 Same reporter, same product. same event, different patient

Other Meds:

Current Illness:

ID: 1037807
Sex: F
Age:
State:

Vax Date: 01/18/2021
Onset Date: 01/20/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: flare up of shingles; disease recurrence; This initial case was missing the following minimum criteria: no adverse event. Upon receipt of follow up information on 30Jan2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer and nurse based on information received by Pfizer from A 58 years old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 18Jan2021 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history included ongoing psoriatic arthritis and shingles. Previous therapy included VIOXX and methotrexate, both for psoriatic arthritis. Concomitant medications included etanercept (ENBREL) for psoriatic arthritis. On 20Jan2021 two days later after received the vaccine the patient had a flare up of shingles. At the time of the reporting event outcome was unknown. No follow-up attempts are possible, information about batch number cannot be obtained

Other Meds: ENBREL

Current Illness: Psoriatic arthritis; Shingles

ID: 1037808
Sex: M
Age:
State: NC

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: shingles; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that a male patient of an unspecified age (reporter's father) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced shingles an unspecified date. The reporter's father took the first dose of the vaccine. After the vaccine his father got shingles and on topical medication. Reporter is asking if it's okay to take the second dose of the vaccine. Therapeutic measures were taken as a result of shingles which included unspecified topical medication. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037809
Sex: F
Age:
State: NJ

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210202; Test Name: Blood pressure; Result Unstructured Data: Test Result:178/120; Comments: at 14:15; Test Date: 20210202; Test Name: pulse; Result Unstructured Data: Test Result:120; Comments: at 14:15

Allergies:

Symptoms: Spike in blood pressure - BP 178/120; Spike in pulse 120; Dizziness; slight chest pains; Arm tingling, turned into full arm pins/needles/Tingling spread through my left underarm and across left side of chest; This is a spontaneous report from a contactable pharmacist (patient). A 26-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL3302), via an unspecified route of administration into the left arm on 02Feb2021 14:15 at a single dose for covid-19 immunisation. Medical history included allergies to penicillin and mushrooms. Patient was not pregnant. Concomitant medication included desogestrel, ethinylestradiol (APRI) for birth control. The patient previously took azithromycin and experienced drug allergy. On 02Feb2021 14:15, patient experienced spike in blood pressure (BP) 178/120 (unit unspecified), spike in pulse 120 (unit unspecified), dizziness, slight chest pains and arm tingling, turned into full arm pins/needles then tingling spread through her left underarm and across the left side of chest. The patient was treated with potassium tablets in the emergency room. Outcome of events was recovered on an unspecified date.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event blood pressure increased cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: APRI

Current Illness:

ID: 1037810
Sex: F
Age:
State: NC

Vax Date: 02/01/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital: Y

Lab Data: Test Date: 20210201; Test Name: EKG; Result Unstructured Data: Test Result:very erratic; Test Date: 20210201; Test Name: labs; Result Unstructured Data: Test Result:unknown results; Test Date: 20210201; Test Name: Troponins; Result Unstructured Data: Test Result:unknown results

Allergies:

Symptoms: hypokalemia; heart started pounding hard/diagnosed with heart palpitations and hypokalemia; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EL9262), via an unspecified route of administration on 01Feb2021 at a single dose for COVID-19 immunization. Medical history included preexisting cardiac issues, she has heart arrhythmia, PAC's and PVC's (all ongoing). The patient's concomitant medications were not reported. On 01Feb2021, later that night (about 12 hours after vaccination), patient's heart started pounding hard. She stated that she has preexisting cardiac issues, she has heart arrhythmia and also has PAC's and PVC's. This is what she used to experience years ago before she was treated with medication. During event on 01Feb2021, EMT that came did EKG at the house, they were concerned about what was seen and patient was taken to Emergency Department and was given some medication to slow her heart rate down. Her EKG was "very erratic" and she was given Cardizem which resolved the issue quickly and was also given some Potassium chloride. Troponins and labs drawn on 01Feb2021. The patient was diagnosed with heart palpitations and hypokalemia. She received new cardiac home medications to take and referral to see Cardiologist next week. The patient was wondering if these were side effects from vaccine. Outcome of the events was unknown. The patient was hospitalized for the events.

Other Meds:

Current Illness: Cardiac arrhythmia (preexisting cardiac issues); Premature atrial contraction (preexisting cardiac issues); Premature ventricular contractions

ID: 1037811
Sex: F
Age:
State: AR

Vax Date: 02/02/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rectal Bleeding; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE , solution for injection, lot number: EN5318, expiration date not reported), via an unspecified route of administration on the right arm on 02Feb2021 10:45 at single dose for COVID-19 immunization. Medical history included osteoporosis and allergic reaction to penicillin. The patient is not pregnant. The patient has no prior COVID vaccination. There was no other vaccine given within four weeks. Concomitant medication included atorvastatin, calcium, magnesium. The patient experienced rectal bleeding on 03Feb2021 09:00. Patient reported that she had her first shot yesterday morning and today when she went to the bathroom she has rectal bleeding, bright red blood, which is not normal for her. The patient was not tested for COVID post vaccination. Outcome of the event was unknown.

Other Meds: ATORVASTATIN; CALCIUM; MAGNESIUM

Current Illness:

ID: 1037812
Sex: F
Age:
State: NY

Vax Date: 01/18/2021
Onset Date: 01/22/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: I had an abscess tooth that became infected; UTI; headache; stomach bloating; pressure and discomfort; blood in my urine; This is a spontaneous report from a contactable consumer (patient herself). A 52-year-old female received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 18Jan2021 at 10:30 AM as a single dose for COVID-19 immunization. The patient had no relevant medical history. The patient ha d no allergies to medications, food, or other products. The patient was not diagnosed with COVID-19 prior to vaccination, has not been tested for COVID-19 since the vaccination, and was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine and also did not receive any other medication within two weeks of vaccination. The patient had a headache on 22Jan2021 for 5 days. She also had stomach bloating and pressure and discomfort on 22Jan2021. It was reported that when she saw blood in her urine, she went to a walk-in and was diagnosed with a UTI on 22Jan2021. She did 7 days of an antibiotic. Then on 30Jan2021, she had an abscess tooth that became infected. It was reported that the patient received antibiotics for both infections. It was reported that the events result in a doctor or other healthcare professional office/clinic visit and an Emergency room/department or urgent care. Outcome of the events was recovering. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect).

Other Meds:

Current Illness:

ID: 1037813
Sex: M
Age:
State: WI

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210127; Test Name: temperature; Result Unstructured Data: Test Result:96.5 degrees; Test Date: 20210127; Test Name: temperature; Result Unstructured Data: Test Result:98 degrees; Test Date: 20210127; Test Name: temperature; Result Unstructured Data: Test Result:93.7 degrees; Comments: orally; Test Date: 20210127; Test Name: temperature; Result Unstructured Data: Test Result:92.7; Test Date: 20210127; Test Name: temperature; Result Unstructured Data: Test Result:93.2 degrees; Test Date: 20210128; Test Name: temperature; Result Unstructured Data: Test Result:93-94 degrees; Test Date: 202005; Test Name: antibody studies; Test Result: Negative

Allergies:

Symptoms: Hypothermia/A temperature of 93.7 orally/temperature was 92.7/went down to 93.2 degrees; Chills; The arm he received the injection in was tender however progressed to mild to moderately painful/arm was suddenly painful; Shaking; Injection site tenderness; This is a spontaneous report from a contactable physician (patient). A 77-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot: EL9262, expiry: unknown), via an unspecified route of administration in the left arm on 26Jan2021 15:30 at a single dose for protection from the virus at the Physician Office. Medical history included type 2 diabetes mellitus from 2011 and ongoing. The patient also thought he had a Covid respiratory infection in Feb2020. He had a prolonged moderate to severe respiratory infection. He thought at first that he had the flu, but he had a flu shot. He thinks he had Covid. He had antibody studies in May2020 (last spring) that were negative. The patient has no concomitant medications. The patient previously had influenza vaccine (flu shot). The patient reported hypothermia after getting the first dose of the Pfizer Covid 19 vaccine. On the same day of vaccination (26Jan2021), he had injection site tenderness. The next day, (27Jan2021), his arm was suddenly painful; he began to have chills 29 hours after receiving the vaccine (27Jan2021) and was shaking. He also had a temperature of 93.7 orally, confirmed with two different digital thermometers. He took his temperature with a new electronic thermometer that he purchased at a pharmacy. His temperature was 92.7 on 27Jan2021. He repeated it with another electronic thermometer. The first evening (27Jan2021), his temperature went to 96.5 to 98 degrees. Then it went down to 93.2 degrees. He covered up with blankets and his temperature increased and the chills stopped. He stated that this was hypothermia. He had low temperatures the following day (28Jan2021) as well, his temperature was 93-94 degrees. His temperature was 93.7 degrees. Other times he checked his temperature and it was 96.5 degrees. When his temperature was low the first time, it only lasted for about three hours. The second time it happened he went to bed and covered up. It lasted for an hour or two. He noticed it again two days ago. The patient also stated the arm he received the injection in was tender however progressed to mild to moderately painful when he experienced the chills and low temperatures. The arm tenderness after getting the vaccine was very mild. He noticed it when he rolled over on his arm. He took some Tylenol for it. His son is an internist. He said the hypothermia was medically significant. His son also said hypothermia is equivalent to a fever in the elderly. The patient wanted to know if there have been any reports of hypothermia after the administration of the vaccine. He has concerns about this occurring after the second dose. He is scheduled to receive the second dose on 15Feb2021 or 16Feb2021. The outcome of the event hypothermia was recovered on 30Jan2021 and pain in arm recovered on 27Jan2021. The outcome of the other events was unknown. The events hypothermia, arm pain and injections site tenderness were assessed as related to BNT16B2.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported hypothermia and the administration of the COVID-19 vaccine, BNT162B2, based on the reasonable temporal association and lacking alternative explanations. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.

Other Meds:

Current Illness: Type 2 diabetes mellitus

ID: 1037814
Sex: M
Age:
State: MA

Vax Date:
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: covid; Test Result: Positive

Allergies:

Symptoms: Just tested positive for covid.; Just tested positive for covid.; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect from a contactable consumer (patient's wife) reported for a male patient (husband). A male patient of an unspecified age received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received their first dose. Just tested positive for covid on an unspecified date. The outcome of the events was unknown. Information on lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037815
Sex: F
Age:
State:

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Name: CT scan; Result Unstructured Data: Test Result:Unknown result; Test Name: MRI scan; Result Unstructured Data: Test Result:Unknown result

Allergies:

Symptoms: She almost instantly completely lost hearing in her right ear / loss of hearing; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on 28Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient reported she had the first shot of the vaccine on 28Jan2021, then on 30Jan2021 she reported that she almost instantly completely lost hearing in her right ear. She said it hasn't changed since. She already had a CT scan and MRI scan with her doctor, and she wanted to eliminate the vaccine shot as the cause of her loss of hearing. Outcome of the event was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037816
Sex: M
Age:
State:

Vax Date: 01/22/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital: Y

Lab Data: Test Date: 20210202; Test Name: test for COVID-19; Test Result: Positive

Allergies:

Symptoms: broken hip; fell out of bed; positive test for COVID19; This is a spontaneous report from a contactable consumer (patient's child). An 80-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration on 22Jan2021 at a single dose for COVID-19 immunisation. The patient's medical history included parkinson's disease. Concomitant medications were not reported. The patient was scheduled to receive the second dose on 12Feb2021. Yesterday (01Feb2021), the patient fell out of bed with a broken hip. The patient was hospitalized and was scheduled for surgery today (02Feb2021) with a positive test for COVID-19. Outcome of the events was unknown. The reporter was asking if the vaccine would register a false positive on a rapid test and if her father is positive for COVID in between both doses of the vaccine, is it recommended that he not get the shot. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037817
Sex: M
Age:
State: LA

Vax Date: 01/09/2021
Onset Date: 01/01/2021
Rec V Date: 02/18/2021
Hospital: Y

Lab Data: Test Date: 202101; Test Name: CT; Result Unstructured Data: Test Result:Unknown results; Test Date: 202101; Test Name: Echo; Result Unstructured Data: Test Result:Unknown results; Test Date: 202101; Test Name: MRI; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210111; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Unable to comprehend description of movie displayed on monitor/did not make convey idea, but each word was understood; word finding difficulty; Medical history included Crohn's and prostate cancer (CA)/vedolizumab (ENTYVIO); Medical history included Crohn's and prostate cancer (CA)/vedolizumab (ENTYVIO); This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: El1283), via an unspecified route of administration, left arm, first dose on 09Jan2021 16:00 at a single dose and for COVID-19 immunization. Medical history included Crohn's and prostate cancer (CA). The patient has no known allergies. Concomitant medication included celecoxib, vedolizumab (ENTYVIO), vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) and vitamin b complex. The patient also takes "garlic multi". The patient had no other vaccine in four weeks. The patient has no COVID prior to vaccination. Covid test via nasal swab on 11Jan2021 with result of negative. On 11Jan2021 at 19:30, the patient was unable to comprehend description of movie displayed on monitor. Words did not make convey idea, but each word was understood. The patient went to hospital for transient ischaemic attack (TIA), no findings overnight then at home word finding difficult about 12 hours later (Jan2021). The patient was brought back to the hospital, no evidence of TIA or cerebrovascular accident (CVA). The adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care and hospitalization for four days. The patient recovered with lasting effects. The patient had MRI, CT and ECHO with unknown results in Jan2021. The patient received statins, topiramate magnesium infusion as treatment. The patient received the second dose (lot number: El9265) via an unspecified route of administration, right arm on 30Jan2021 for COVID-19 immunization.

Other Meds: CELECOXIB; ENTYVIO; VITAMIN C [ASCORBIC ACID]; VIT B COMPLEX

Current Illness:

ID: 1037818
Sex: F
Age:
State: NY

Vax Date: 01/14/2021
Onset Date: 01/18/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210120; Test Name: Nasal Swab, PCR; Test Result: Negative

Allergies:

Symptoms: R sided neck and facial swelling with nerve pain; R sided neck and facial swelling with nerve pain; R sided neck and facial swelling with nerve pain; decreased hearing to my R ear; The pain was worse in my R jaw- both upper and lower teeth pain; The pain was worse in my R jaw- both upper and lower teeth pain; Feeling of heaviness to my R eye, R cheek, R side of my tongue; Feeling of heaviness to my R eye, R cheek, R side of my tongue; Feeling of heaviness to my R eye, R cheek, R side of my tongue; decreased taste on the R side of my tongue; fatigue; muscle aches; woke up with painfull (pins and needle sensation) swollen hands; woke up with painfull (pins and needle sensation) swollen hands; woke up with painfull (pins and needle sensation) swollen hands; This is a spontaneous report from a contactable nurse (patient). A 57-year-old female patient received the 2nd dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Lot number: EL 3248, Expiration date: Apr2021), via an unspecified route of administration at the left arm on 14Jan2021 08:15 at a single dose for covid-19 immunization. The vaccine was administered in a hospital. Medical history includes shrimp allergy. The patient was not pregnant at the time of vaccination. Concomitant medication was not reported. Historical vaccine includes 1st dose of bnt162b2 for COVID-19 immunization on 24Dec2020 09:30 AM, at the left arm, Lot number: EK9231 and Expiration date: Apr2021 at age of 57 years. The patient developed extreme fatigue, some muscle aches on 18Jan2021. She woke up with painful (pins and needle sensation) swollen hands. Took some TYLENOL and elevated them for a few hrs. The swelling subsided by the afternoon. On 19Jan2021, she developed R sided neck and facial swelling with nerve pain. The pain was worse in her R jaw- both upper and lower teeth pain, nerve pain extending from the side of my R ear up to my R eye and temple area. Feeling of heaviness to her R eye, R cheek, R side of her tongue, decreased hearing to her R ear (sounds muffled like being under water), decreased taste on the R side of heer tongue. Took benedryl and tylenol all day. On 20Jan2021, after a restless night due to the nerve pain (not relieved by tylenol) went to work but the swelling worsened so she was sent to the ED. They treated me with IV decadron, IV benedry, IV zofran- which immediately took away the swelling. The events result to Emergency Room/ Urgent Care Visit. Prior to vaccination the patient was not diagnosed with COVID-19. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. On 20Jan2021, the patient had Nasal Swab, PCR, covid test result was negative. The events were assessed as non-serious by the reporter, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. The outcome of the events was not recovered.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness:

ID: 1037819
Sex: F
Age:
State: FL

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210130; Test Name: Covid; Test Result: Positive

Allergies:

Symptoms: Caller had Covid vaccine on 28Jan and tested positive for Covid today; Caller had Covid vaccine on 28Jan and tested positive for Covid today; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 28Jan2021 at SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had Covid vaccine on 28Jan2021 and tested positive for Covid today 30Jan2021. She is wondering what to do about 2nd dose and wonders if this is normal. The patient underwent lab tests and procedures which included COVID: positive on 30Jan2021. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1037820
Sex: M
Age:
State: KY

Vax Date: 01/13/2021
Onset Date: 02/01/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data: Test Date: 20210201; Test Name: SARS-Cov2-RT PCR; Test Result: Positive ; Comments: Nasal Swab

Allergies:

Symptoms: positive COVID-19 test; positive COVID-19 test; This is a spontaneous report received from a contactable nurse. An 88-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection) Intramuscularly on 13Jan2021 at single dose for COVID-19 immunization in a nursing home/senior living facility. Medical history included s/p cerebrovascular accident (CVA), Insulin dependent diabetes mellitus (IDDM) and hypertension (HTN). The patient had no allergies with medications, food or other products. Concomitant medication included insulin glargine (LANTUS). The patient was not diagnosed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The resident (patient) tested positive in the SARS-Cov2-RT PCR (nasal swab) on 01Feb2021. Patient did not receive treatment for the adverse event. Event was considered by the reporter as non-serious. Outcome of events was recovering. Information on the lot number and batch number has been requested.; Sender's Comments: Based on the information currently available, lack of efficacy of the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine.

Other Meds: LANTUS

Current Illness:

ID: 1037821
Sex: F
Age:
State: CA

Vax Date: 01/30/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable healthcare professional (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9261; Expiration date was not reported) on 30Jan2021 (15:00) at a isngle dose on the right arm, with route of administration unspecified, for COVID-19 immunization. Medical history included asthma and allergies to non-steroidal anti-inflammatory drugs (NSAIDS). Concomitant medications included unspecified medications. The patient previously took omalizumab (XOLAIR), and had drug allergy. The patient was not pregnant at the time of vaccination. On 30Jan2021 (17:00), the patient had diarrhea. The patient did not receive any treatment for the reported event. The outcome of the event, diarrhea, was recovered on an unspecified date in 2021. The patient was not diagnosed with COVID-19 prior to the vaccination, and had not been tested since the vaccination.

Other Meds:

Current Illness:

ID: 1037822
Sex: F
Age:
State: WI

Vax Date: 02/01/2021
Onset Date: 02/02/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pass out; vomiting; Severe muscle pains; Severe headache; This is a spontaneous report from a contactable Other HCP (patient). A 48-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 01Feb2021 at 10:00 at single dose in left arm for COVID-19 immunisation at the age of 48-year-old. Lot number was EL3248. Medical history included asthma, migraine headaches, thyroiditis. Concomitant medications included levothyroxine, fluoxetine, bupripion, clonazepam. The patient was not pregnant. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 10Jan2021 at 15:00 at single dose in right arm for COVID-19 immunisation at the age of 48-year-old. On 02Feb2021 at 23:00, the patient experienced severe vomiting which kept the patient up most of the night, she had to stay by toilet; the patient was feeling like she was going to pass out with any movement, the patient experienced severe muscle pains that felt almost like bones were breaking inside; the patient experienced severe headache; the patient almost took her-self to the emergency room in the middle of the night, but she did not want to expose her compromised immune system to others. The patient was not treated for the events. The patient was recovering from the events.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the LOC and other reported events due to temporal relationship Additional information is needed to better assess the case, including complete medical history, diagnostics including chemistry panel, Head CT/MRI and EKG, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: LEVOTHYROXINE; FLUOXETINE; BUPROPION; CLONAZEPAM

Current Illness:

ID: 1037823
Sex: F
Age:
State:

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a non-contactable consumer. A female patient of unspecified age received the first dose of bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration on 03Feb2021 at a single dose for COVID-19 immunization. It was unknown if patient was pregnant at the time of vaccination. It was unknown if the patient was diagnosed with COVID-19 prior to vaccination. Medical history and concomitant medications were not reported. The patient reported that after vaccine administration, she could barely lift her arm on 03Feb2021. It was unknown if treatment was received for the events. Outcome of the events was recovering. The reporter assessed the events as non-serious. Since the vaccination, it was unknown if patient has been tested for COVID-19. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1037824
Sex: F
Age:
State: IN

Vax Date: 01/25/2021
Onset Date: 01/25/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swollen and blistered lips; Swollen and blistered lips; Itching inside my mouth and throat, and on my hands and legs; Itching inside my mouth and throat, and on my hands and legs; Itching inside my mouth and throat, and on my hands and legs; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9262, expiration date was not reported) given at 64 years of age, via an unspecified route of administration in the left arm on 25Jan2021 14:30 at a single dose for COVID-19 immunisation. Medical history included known allergies. Concomitant medication included thyroid (ARMOUR THYROID), aluminium hydroxide gel, dried, magnesium carbonate (PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]), and metronidazole. The patient was not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was she tested for COVID-19 since the vaccination. It was reported that less than one hour after receiving the vaccine on 25Jan2021 at 04:00 PM, the patient developed itching inside her mouth and throat, and on her hands and legs. The itching stopped with BENADRYL. Four days later on 29Jan2021 14:30, she developed swollen and blistered lips. The outcome of the events was recovering and were reported non-serious. Treatment received for the events included steroid injection five days after the vaccine. The events resulted to doctor or other healthcare professional office/clinic visit then emergency room/department or urgent care.

Other Meds: ARMOUR THYROID; PEPCID [ALUMINIUM HYDROXIDE GEL, DRIED;MAGNESIUM CARBONATE]; METRONIDAZOLE

Current Illness:

ID: 1037825
Sex: F
Age:
State: FL

Vax Date: 01/18/2021
Onset Date: 01/19/2021
Rec V Date: 02/18/2021
Hospital: Y

Lab Data: Test Name: bacteria test; Result Unstructured Data: Test Result:normal; Test Name: Creat; Result Unstructured Data: Test Result:1.0; Test Name: Creat; Result Unstructured Data: Test Result:1.6; Comments: Monday it was 1.6; Test Name: Creat; Result Unstructured Data: Test Result:1.9; Comments: Friday it was 1.9; Test Name: blood; Result Unstructured Data: Test Result:everything seemed ok; Test Name: EKG; Result Unstructured Data: Test Result:everything seemed ok; Test Name: Heart; Result Unstructured Data: Test Result:banging fiercely; Test Name: white blood cell count; Result Unstructured Data: Test Result:elevated; Test Name: white blood cell count; Result Unstructured Data: Test Result:Elevated

Allergies:

Symptoms: Nausea; Dizziness and room spinning; room was spinning; her white blood cell count was elevated; Kidney failure and allergic reaction; Allergic Reaction; still wasn't feeling normal; Could not keep head up and was in bed; breathless; extreme fatigue; exhausted and weak; Heart was banging fiercely; Totally dehydrated; Urinating a great deal more; Chills, shakes and felt terrible; Chills, shakes and felt terrible; sicker every single day/sick/felt terrible; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration on the left arm on 18Jan2021 14:30 at a single dose for prevention for COVID. Medical history included hip replacement on 04Jan2021 and fibromyalgia (When her children were younger, she was told she had Fibromyalgia). Family history includes diabetes (father late onset) and very rare cancer (mother). There were no concomitant medications. It was reported that the patient received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine and got sick the next day (19Jan2021). She also mentioned that she got sicker every single day. Then after 8-9 days, she said she started to feel better, but still wasn't feeling normal. She said she had extreme fatigue, was breathless, and felt exhausted and weak on an unspecified date. She said she was supposed to receive the 2nd dose of the vaccine this Monday (unspecified date), but because of her side effects, she was told that she can come back to receive the 2nd dose after 6 weeks. She wants to know if this is acceptable. The patient reported that on 19Jan2021, she woke up in the middle of the night with chills, shakes, and felt terrible. She cancelled her plans for Tuesday (as reported). On Wednesday, she forced herself to get up and went out for lunch and came home. She could not keep her head up and went back to bed and that lasted several days. It got worse before it got better. She ended up being hospitalized for 4 days (25Jan2021 to 29Jan2021). It appeared to be she was in Kidney Failure and experienced allergic reaction on 25Jan2021 and her white blood cell count was elevated (unspecified date). She went to the ER and they kept her 6-8 hours and discharged her on a Friday and by Monday, she was admitted to the hospital. The first ER visit, she was there for 6-8 hours and they sent her home. They gave her IV fluids and took a lot of tests. The patient's first ER visit was on 22Jan2021, and was kept for 6-8 hours and released. She was given IV fluids and they did a lot of tests. She went to see her doctor and sent her to the emergency room. They took her blood, EKG and everything seemed ok. Creat was 1.0 and by Monday it was 1.6 and then on Friday it was 1.9 (unspecified dates). She was admitted to hospital on Monday and they gave her IV fluids and did kidney test and admitted her as soon as she could get a room. She never had a problem before with her kidneys. They did bacteria test and they were normal. The patient called her doctor on 24Jan2021, because she was nauseous, dizzy, and room was spinning and she felt worse. She went to his office on Monday morning and he put her right in the hospital (unspecified date). She got worse and now it is improved. Heart was banging fiercely on 22Jan2021 20:00. They took an Echocardiogram. She has never had a cardiac problem and could not find anything wrong with her heart. The patient started feeling a bit better. She was sick as can be through Sunday. By Tuesday (unspecified date), she was a little better and today is a little better. She is urinating a great deal more because of fluids, but later said it started the day after she got it. She had to get an aide to take care of her. The patient experienced totally dehydrated on 22Jan2021 14:00 and urinating a great deal more on 19Jan2021 03:00. Therapeutic measures were taken as a result of kidney failure, allergic reaction and white blood cell count was elevated. The outcome of the events sicker every single day/sick, chills, shakes and felt terrible was not recovered; event could not keep head up and was in bed recovered with sequel; events nausea, dizziness and room spinning, heart was banging fiercely, totally dehydrated, urinating a great deal more was recovering; while unknown for the rest of the events.

Other Meds:

Current Illness:

ID: 1037826
Sex: F
Age:
State: NY

Vax Date: 01/29/2021
Onset Date: 01/30/2021
Rec V Date: 02/18/2021
Hospital: Y

Lab Data:

Allergies:

Symptoms: Bell's Palsy; This is a spontaneous report from a contactable other health care professional (patient). A 51-year-old female patient (Pregnant: No) received second dose of bnt162b2 (Lot number: EL9264), via an unspecified route of administration in left arm on 29Jan2021 14:30 at single dose for COVID-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing. Concomitant medication included ammonium succinate, calcium succinate, glutamate sodium, glycine, magnesium succinate, tocopheryl acetate, zinc difumarate hydrate (AMBEREN), collagen, bifidobacterium longum, lactobacillus acidophilus, lactobacillus rhamnosus (PROBIOTICS) and multi-vitamin. The patient previous received first dose of bnt162b2 (Lot number: EL0143), via an unspecified route of administration in left arm on 07Jan2021 14:00 for COVID-19 immunization. The patient experienced bell's palsy (hospitalization) on 30Jan2021 09:00. The patient was hospitalized for bell's palsy for 2 days. The patient was admitted on 30Jan2021 to hospital and diagnosed with Bell's Palsy. Treatment included: Prednisone and Valacyclovir. Facility type vaccine was hospital. No other vaccine in four weeks. No COVID prior vaccination. No COVID tested post vaccination. Not Known allergies. The outcome of event was not resolved.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: AMBEREN; COLLAGEN; PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS]

Current Illness:

ID: 1037827
Sex: M
Age:
State:

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bleeding down his arm afterward; He received a dose in his left arm, and noticed he was bleeding down his arm afterward/He had another dose given in his right arm; This is a spontaneous report from a contactable consumer (patient). A 62-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, lot number and expiry date not reported), first in the left arm and second dose in the right arm, both via an unspecified route of administration on 02Feb2021 at single doses for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient received his first round of Pfizer-Biontech Covid19 vaccine yesterday 02Feb2021. He received a dose in his left arm, and noticed he was bleeding down his arm afterward, which was out of character for him. When he alerted his nurse who had administered the vaccine, she discussed it with a colleague who said "go ahead and give him another one". He had another dose (second dose) given in his right arm on 02Feb2021. Patient stated he's "feeling fine". He wanted to know if he still needs to get the second dose in the series. It was also further reported as they gave him the shot in the left arm and he started to bleed. He got a 2nd one in the right arm. He was feeling fine. The nurse asked another nurs- and she said, "go ahead and give him another one". The outcome of the event bleeding down his arm afterward was unknown. Information on the Batch/Lot number has been requested.

Other Meds:

Current Illness:

ID: 1037828
Sex: F
Age:
State: PA

Vax Date: 12/29/2020
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: After the first vaccine, she started getting them a little/after the first vaccine, caller started to have hot flashes again; She had a hormone reaction to it; affecting her mental health; This is a spontaneous report from a contactable nurse (patient). A 41-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EJ1686), via an unspecified route of administration on 29Dec2021 at single dose for covid-19 immunization. Medical history included ongoing artificial menopause (Surgical menopause, since she was 36). The patient's concomitant medications were not reported. After the first vaccine, caller started to have hot flashes again, and after the second vaccine they became unbearable. She had a reaction to the vaccine. She had a hormone reaction to it. The caller did research herself to look up hormonal things about the Pfizer vaccine, but she could not find anything. The only information she found was on pregnancy and breast feeding, and low estrogen with COVID. They had significantly subsided over the last year and half to two years. After the first vaccine, she started getting them a little. Then, after second vaccine her hot flashes started being unbearable. She was unsure if it had to do with the vaccine, but she felt like it did. She spoke with nurses she works with. They too had hormonal issues after the vaccine. One had difficulty getting her period for 9 months to a year, but then got their period. She talked to people in menopause who have not had their period for a year, and had one after the vaccine. She talked to women with PCOS that had difficulty getting their period, but got their period after the vaccine. She also talked to women who had normal menopause, that hadn't had their period in a long time get a period. She said this was all generalized information. She doesn't have the specifics for the people that reported it. There was something hormonal going on. It was literally driving her nuts. Her first vaccine she got on the 29Dec2020, Lot number: EJ1686. Her second vaccine she got on 19Jan2021, lot number: EL9261. This all started a week after the first shot, and got worse after the second. She felt like this was medically significant. There was a fine line between medical issues and mental health, and she felt like this was affecting her mental health. Outcome of events was not recovered. Reaction assessed: after the first vaccine, caller started to have hot flashes again, and after the second vaccine they became unbearable. Source of assessment: Primary Source Reporter; Method of assessment: Global Introspection; Drug result: Related.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds:

Current Illness: Surgical menopause (Surgical menopause)

ID: 1037829
Sex: M
Age:
State: FL

Vax Date: 01/23/2021
Onset Date:
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3248), via an unspecified route of administration on 23Jan2021 at SINGLE DOSE for COVID-19 immunization. Medical history was none. There were no concomitant medications. The patient had soreness in the shoulder for only one day and he had bruising. No treatment received. The outcome was unknown.

Other Meds:

Current Illness:

ID: 1037830
Sex: F
Age:
State: DE

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 02/18/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bleeding; seeping from lower leg; This is a spontaneous report from a contactable consumer. A 90-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: expiry date: unknown) via an unspecified route of administration in the right arm, on 03Feb2021 10:30, at a single dose, for COVID-19 immunization. Medical history included breast cancer and chronic obstructive pulmonary disease (COPD). The patient has no known allergies. The patient has many unspecified concomitant medications. The patient is not pregnant at the time of vaccination. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The vaccine was administered in other facility. On 03Feb2021, at 11:00 A.M., the patient experienced bleeding/seeping from lower leg. The patient did not receive treatment for the events. Outcome of the events not recovered. Information about lot/batch number has been requested.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm